Andreas Wallnöfer

545 total citations
16 papers, 439 citations indexed

About

Andreas Wallnöfer is a scholar working on Molecular Biology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Andreas Wallnöfer has authored 16 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 5 papers in Psychiatry and Mental health. Recurrent topics in Andreas Wallnöfer's work include Nitric Oxide and Endothelin Effects (7 papers), Ion Transport and Channel Regulation (5 papers) and Ion channel regulation and function (4 papers). Andreas Wallnöfer is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Ion Transport and Channel Regulation (5 papers) and Ion channel regulation and function (4 papers). Andreas Wallnöfer collaborates with scholars based in Switzerland, Netherlands and Germany. Andreas Wallnöfer's co-authors include Urs T. Rüegg, Cynthia Cauvin, Sheila W. Weir, G Thiel, Rebecca L. Jones, Michel D. Ferrari, Cornelia Weber, Isabelle Binet, Arne May and Harm J. Gijsman and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Pain and Kidney International.

In The Last Decade

Andreas Wallnöfer

16 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Wallnöfer Switzerland 10 158 125 124 93 91 16 439
Kathryn W. Schenck United States 13 200 1.3× 86 0.7× 314 2.5× 238 2.6× 114 1.3× 25 672
Pramod R. Saxena Netherlands 13 151 1.0× 83 0.7× 217 1.8× 188 2.0× 205 2.3× 18 521
L. J. Ignarro United States 10 301 1.9× 192 1.5× 143 1.2× 62 0.7× 114 1.3× 12 701
Seyed Ali Gaskari Iran 11 121 0.8× 48 0.4× 79 0.6× 170 1.8× 63 0.7× 15 624
Miriam Álvarez-Guerra France 10 84 0.5× 32 0.3× 190 1.5× 70 0.8× 54 0.6× 24 521
H. Hinterberger Australia 13 106 0.7× 249 2.0× 82 0.7× 45 0.5× 24 0.3× 31 562
Gary A. Walter United States 15 92 0.6× 33 0.3× 191 1.5× 239 2.6× 55 0.6× 18 634
C.A. Hamilton United Kingdom 14 157 1.0× 39 0.3× 313 2.5× 202 2.2× 212 2.3× 36 737
Hiroaki Hisa Japan 16 302 1.9× 37 0.3× 322 2.6× 195 2.1× 289 3.2× 94 799
Shinji Sudoh Japan 12 321 2.0× 135 1.1× 128 1.0× 89 1.0× 33 0.4× 17 610

Countries citing papers authored by Andreas Wallnöfer

Since Specialization
Citations

This map shows the geographic impact of Andreas Wallnöfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Wallnöfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Wallnöfer more than expected).

Fields of papers citing papers by Andreas Wallnöfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Wallnöfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Wallnöfer. The network helps show where Andreas Wallnöfer may publish in the future.

Co-authorship network of co-authors of Andreas Wallnöfer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Wallnöfer. A scholar is included among the top collaborators of Andreas Wallnöfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Wallnöfer. Andreas Wallnöfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Binet, Isabelle, Andreas Wallnöfer, Cornelia Weber, Richard D. Jones, & G Thiel. (2000). Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A. Kidney International. 57(1). 224–231. 83 indexed citations
2.
Dingemanse, Jasper, Andreas Wallnöfer, Ronald Gieschke, Theodor W. Guentert, & R. Amrein. (1998). Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the “serotonin syndrome”*. Clinical Pharmacology & Therapeutics. 63(4). 403–413. 12 indexed citations
3.
Steveninck, Alfred L van, Andreas Wallnöfer, Rik C. Schoemaker, et al.. (1997). A study of the effects of long‐term use on individual sensitivity to temazepam and lorazepam in a clinical population. British Journal of Clinical Pharmacology. 44(3). 267–275. 35 indexed citations
4.
Dingemanse, Jasper, J Kneer, Andreas Wallnöfer, et al.. (1996). Pharmacokinetic-Pharmacodynamic Interactions Between Two Selective Monoamine Oxidase Inhibitors: Moclobemide and Selegiline. Clinical Neuropharmacology. 19(5). 399–414. 16 indexed citations
5.
May, Arne, Harm J. Gijsman, Andreas Wallnöfer, et al.. (1996). Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain. 67(2). 375–378. 100 indexed citations
6.
Wallnöfer, Andreas, T. W. Guentert, S.‐Å. Eckernäs, & Jasper Dingemanse. (1995). Moclobemide and fluvoxamine co‐administration: A prospective study in healty volunteers to investigate the potential development of the ‘serotonin syndrome’. Human Psychopharmacology Clinical and Experimental. 10(1). 25–31. 9 indexed citations
7.
Wallnöfer, Andreas, Rik C. Schoemaker, Adam F. Cohen, et al.. (1993). Effect of Isotretinoin on Endogenous Tissue-Type Plasminogen Activator (t-PA) and Plasminogen Activator Inhibitor 1 (PAI-1) in Humans. Thrombosis and Haemostasis. 70(6). 1005–1008. 7 indexed citations
8.
Wallnöfer, Andreas. (1993). [Psychopharmacological models of drug dependence. Key role of the dopaminergic mesolimbic system].. PubMed. 82(37). 999–1003. 1 indexed citations
9.
Dingemanse, Jasper, S.‐Å. Eckernäs, A. Grahnén, G. Michael Hass, & Andreas Wallnöfer. (1991). Tolerability and safety of combined fluoxamine and moclobemide in healthy volunteers. European Neuropsychopharmacology. 1(3). 455–455. 2 indexed citations
10.
Rüegg, Urs T., Andreas Wallnöfer, Sheila W. Weir, & Cynthia Cauvin. (1989). Receptor-Operated Calcium-Permeable Channels in Vascular Smooth Muscle. Journal of Cardiovascular Pharmacology. 14. S49–S58. 63 indexed citations
11.
Wallnöfer, Andreas, Urs T. Rüegg, & Cynthia Cauvin. (1989). The Mechanism of Action of Endothelin-1 as Compared with Other Agonists in Vascular Smooth Muscle. Journal of Cardiovascular Pharmacology. 13. S23–31. 51 indexed citations
12.
Rüegg, Urs T., Andreas Wallnöfer, Sheila W. Weir, & Cynthia Cauvin. (1989). Receptor-Operated Calcium-Permeable Channels in Vascular Smooth Muscle. Journal of Cardiovascular Pharmacology. 14. S49–S58. 5 indexed citations
13.
Wallnöfer, Andreas, et al.. (1989). Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells. American Journal of Physiology-Cell Physiology. 257(4). C607–C611. 22 indexed citations
14.
Cauvin, Cynthia, Sheila W. Weir, Andreas Wallnöfer, & Urs T. Rüegg. (1988). Agonist-Induced Activation of Rat Mesenteric Resistance Vessels. Journal of Cardiovascular Pharmacology. 12(Supplement). 128–133. 12 indexed citations
15.
Cauvin, Cynthia, Sheila W. Weir, Andreas Wallnöfer, & Urs T. Rüegg. (1988). Agonist-Induced Activation of Rat Mesenteric Resistance Vessels. Journal of Cardiovascular Pharmacology. 12. 128–133. 3 indexed citations
16.
Wallnöfer, Andreas, Cynthia Cauvin, & Urs T. Rüegg. (1987). Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells. Biochemical and Biophysical Research Communications. 148(1). 273–278. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn W. Schenck Breakdown of academic impact, for papers by Pramod R. Saxena Breakdown of academic impact, for papers by L. J. Ignarro Breakdown of academic impact, for papers by Seyed Ali Gaskari Breakdown of academic impact, for papers by Miriam Álvarez-Guerra Breakdown of academic impact, for papers by H. Hinterberger Breakdown of academic impact, for papers by Gary A. Walter Breakdown of academic impact, for papers by C.A. Hamilton Breakdown of academic impact, for papers by Hiroaki Hisa Breakdown of academic impact, for papers by Shinji Sudoh
Rankless by CCL
2026